ArticleBiomedicines2026

Rewiring of Molecular Networks Induced by the Combination of Loratadine, Raloxifene, and Sorafenib Leads to the Identification of Clinically Relevant Therapeutic Targets in Hepatocellular Carcinoma.

Fernanda Villarruel-Melquiades et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.